Clinical Trial: Nebulised 3% Hypertonic Saline Versus 0.9% Saline for Treating Patients Hospitalized With Acute Bronchiolitis
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Bronchiolitis
Study Type: INTERVENTIONAL
Official Title: Nebulised 3% Hypertonic Saline Versus 0.9% Saline for Treating Patients Hospitalized With Acute Bronchiolitis: Protocol of a Randomized, Double-blind, Multicentre Trial
Brief Summary:
Bronchiolitis is an acute viral infection of the lower respiratory tract.It is most commonly caused by respiratory syncytial virus (RSV).Only supportive therapy, including suctioning nasal secretions, water-electrolyte balance maintenance, and oxygen supplementation when needed, is recommended.The inhalation of 3% hypertonic saline is not recommended in bronchiolitis management.However, a recently published meta-analysis revealed that the inhalation of hypertonic saline can reduce the risk of hospitalisation for…
Read more